Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation devices market, the increasing prevalence of neurological disorders, the rise in research, and expanding applications of neuromodulation are considered some of the major factors driving the growth of the market. Similarly, the increasing awareness of neurodegenerative disorders across the globe and the development of new clinical devices and technology to overcome neurological diseases are also fueling the markets growth.
Top Driver: Increase in the Number of Neurological DiseasesPatients and Rising Cases of Migraine Patients are Driving the Neuromodulation Devices Market.
Neuromodulation is a type of technology that directly acts upon nerves. This type of technique delivers pharmaceutical agents or electrical stimulation to a targeted region of the nerves within the body. The growing geriatric population across regions such as Asia-Pacific and Europe is leading to an increase in neurological disorders, which is directly impacting the growth of the neuromodulation devices market. For instance, according to data from the Alzheimers Association in 2017, around 5.5 million Americans had Alzheimers, out of which almost 5.3 million of the populations age was 65 years or more, which is also increasing the demand for these devices to enhance the quality of their lives. Additionally, the increase in the need for these devices to improve the quality of life of individuals who are suffering from urinary and faecal incontinence, chronic pain, essential tremor, epilepsy, Parkinsons disease, dystonia, and psychological disorders
Additionally, initiatives taken by private firms and the government to increase awareness associated with neurological disorders and mental health among individuals are growing the market. Furthermore, the agencies present in Japan associated with pharmaceutical and medical device agencies have approved several neurostimulators for pain management since 2010, which include the Eon Mini Precision Spectra by Boston Scientific, St. Jude, and Genesis Spinal Cord Stimulation (SCS) systems.
Neuromodulation Devices to Make Crucial Contributions to the Growth of the Global Neuromodulation Devices Market
Based on the product type, the neuromodulation devices market has been segmented as spinal cord stimulators (SCS), deep brain stimulators (DBS), vagus nerve stimulators (VNS), sacral nerve stimulators (SNS), and transcranial magnetic stimulators (TMS). Spinal cord stimulators (SCS) hold the largest share of product type segments. The increasing prevalence of spinal cord diseases or disorders is fueling the growth of the market. Similarly, the rise in spinal cord issues associated with the ageing population is also driving demand for neuromodulation devices, which in turn is fueling the growth of the market.
Based on end-users, the global neuromodulation devices market has been segmented into hospitals and specialty clinics. Hospitals hold the largest share of the high-paying capacity for adopting new and advanced technology. Further, the presence of a well-equipped infrastructure is also driving the growth of the market.
The Established Healthcare Industry in North America is Driving the Market.
North America has well-developed facilities and infrastructure as compared to other regions. The various medical science, pharmaceutical, and medical device manufacturing companies, research and development centers, healthcare companies, and well-established hospitals and clinics are leading to the growth of the market. Additionally, a rise in the geriatric population in the region is further fueling the growth of the market. Based on countries, the North American region has been segmented as the US and Canada. Technological advancement in countries and increased investments in the development of new technology are thought to be fueling market growth.
Players to Focus on the Development of New Devices and Technology
The presence of companies such as St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioness Inc., EnteroMedics Inc, Nevro Corporation, NeuroPace Inc., Synapse Biomedical, Inc., Neurosigma, Inc., Neuronetics, Inc., Cyberonics, Inc., BioControl Medical, Accellent, DynaMD, Soterix Medical, Inc., and others developing neuromodulation devices
Abbott: In September 2019, Abbott Inc., a healthcare company based in the US, received FDA clearance for Proclaim XR, which is a neurostimulation system for treating patients with chronic pain. These systems are being developed to send doses to change the pain signals from the spinal cord to the brain.
In 2019, NeuroSigma partnered with Teijin Limited to market the NeuroSigma Monarch eTNS system in Japan. Furthermore, this also led to the expansion of the company in Japan.
Scope of the Report
By Product Type
Spinal Cord Stimulators (SCS)
Deep Brain Stimulators (DBS)
Vagus Nerve Stimulators (VNS)
Sacral Nerve Stimulators (SNS)
Transcranial Magnetic Stimulators (TMS)
By Type
Internal
External
By Application
Pain Management
Neurological Disorders
Respiratory Disorders
By End-User
Hospitals
Specialty Clinics
By Region
North America
Europe
Asia Pacific
Rest of the World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Top Driver: Increase in the Number of Neurological DiseasesPatients and Rising Cases of Migraine Patients are Driving the Neuromodulation Devices Market.
Neuromodulation is a type of technology that directly acts upon nerves. This type of technique delivers pharmaceutical agents or electrical stimulation to a targeted region of the nerves within the body. The growing geriatric population across regions such as Asia-Pacific and Europe is leading to an increase in neurological disorders, which is directly impacting the growth of the neuromodulation devices market. For instance, according to data from the Alzheimers Association in 2017, around 5.5 million Americans had Alzheimers, out of which almost 5.3 million of the populations age was 65 years or more, which is also increasing the demand for these devices to enhance the quality of their lives. Additionally, the increase in the need for these devices to improve the quality of life of individuals who are suffering from urinary and faecal incontinence, chronic pain, essential tremor, epilepsy, Parkinsons disease, dystonia, and psychological disorders
Additionally, initiatives taken by private firms and the government to increase awareness associated with neurological disorders and mental health among individuals are growing the market. Furthermore, the agencies present in Japan associated with pharmaceutical and medical device agencies have approved several neurostimulators for pain management since 2010, which include the Eon Mini Precision Spectra by Boston Scientific, St. Jude, and Genesis Spinal Cord Stimulation (SCS) systems.
Neuromodulation Devices to Make Crucial Contributions to the Growth of the Global Neuromodulation Devices Market
Based on the product type, the neuromodulation devices market has been segmented as spinal cord stimulators (SCS), deep brain stimulators (DBS), vagus nerve stimulators (VNS), sacral nerve stimulators (SNS), and transcranial magnetic stimulators (TMS). Spinal cord stimulators (SCS) hold the largest share of product type segments. The increasing prevalence of spinal cord diseases or disorders is fueling the growth of the market. Similarly, the rise in spinal cord issues associated with the ageing population is also driving demand for neuromodulation devices, which in turn is fueling the growth of the market.
Based on end-users, the global neuromodulation devices market has been segmented into hospitals and specialty clinics. Hospitals hold the largest share of the high-paying capacity for adopting new and advanced technology. Further, the presence of a well-equipped infrastructure is also driving the growth of the market.
The Established Healthcare Industry in North America is Driving the Market.
North America has well-developed facilities and infrastructure as compared to other regions. The various medical science, pharmaceutical, and medical device manufacturing companies, research and development centers, healthcare companies, and well-established hospitals and clinics are leading to the growth of the market. Additionally, a rise in the geriatric population in the region is further fueling the growth of the market. Based on countries, the North American region has been segmented as the US and Canada. Technological advancement in countries and increased investments in the development of new technology are thought to be fueling market growth.
Players to Focus on the Development of New Devices and Technology
The presence of companies such as St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioness Inc., EnteroMedics Inc, Nevro Corporation, NeuroPace Inc., Synapse Biomedical, Inc., Neurosigma, Inc., Neuronetics, Inc., Cyberonics, Inc., BioControl Medical, Accellent, DynaMD, Soterix Medical, Inc., and others developing neuromodulation devices
Abbott: In September 2019, Abbott Inc., a healthcare company based in the US, received FDA clearance for Proclaim XR, which is a neurostimulation system for treating patients with chronic pain. These systems are being developed to send doses to change the pain signals from the spinal cord to the brain.
In 2019, NeuroSigma partnered with Teijin Limited to market the NeuroSigma Monarch eTNS system in Japan. Furthermore, this also led to the expansion of the company in Japan.
Scope of the Report
By Product Type
Spinal Cord Stimulators (SCS)
Deep Brain Stimulators (DBS)
Vagus Nerve Stimulators (VNS)
Sacral Nerve Stimulators (SNS)
Transcranial Magnetic Stimulators (TMS)
By Type
Internal
External
By Application
Pain Management
Neurological Disorders
Respiratory Disorders
By End-User
Hospitals
Specialty Clinics
By Region
North America
Europe
Asia Pacific
Rest of the World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global Neuromodulation Devices Market Forces
3.1 Whats Driving the Market
3.2 Porters Five Forces Analysis
3.2.1 Power of Suppliers
3.2.2 Threats From New Entrants
3.2.3 Power of Buyer
3.2.4 Threat From Substitute Product Type
3.2.5 Degree of Competition
Chapter 4 Global Neuromodulation Devices Market -Industry Snapshots
4.1 Overview
4.1.1 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
4.2 Market Overview
4.2.1 Drivers Analysis
4.2.2 Restraint/Challenges analysis
4.2.3 Opportunity Analysis
4.3 Supply Chain/Value Chain Analysis
4.4 Market SWOT Analysis
Chapter 5 Global Neuromodulation Devices Market Analysis, By Type
5.1 Overview
5.2 Internal
5.3 External
Chapter 6 Global Neuromodulation Devices Market Analysis, by Product Type
6.1 Overview
6.1.1 Spinal Cord Stimulators (SCS)
6.1.2 Deep Brain Stimulators (DBS)
6.1.3 Vagus Nerve Stimulators (VNS)
6.1.4 Sacral Nerve Stimulators (SNS)
6.1.5 Transcranial Magnetic Stimulators (TMS)
Chapter 7 Global Neuromodulation Devices Market Analysis, by End-User
7.1 Overview
7.1.1 Hospitals
7.1.2 Specialty Clinics
Chapter 8 Global Neuromodulation Devices Market Analysis, by Application
8.1 Overview
8.1.1 Pain Management
8.1.2 Neurological Disorders
8.1.3 Respiratory Disorders
Chapter 9 Neuromodulation Devices Market Analysis by Region
9.1 Key Findings for Neuromodulation Devices Market- By region
9.2 Overview
9.2.1 Global Neuromodulation Devices Market Analysis, By Type, 2019 - 2030
9.2.2 Global Neuromodulation Devices Market Analysis, By Product Type, 2019 - 2030
9.2.3 Global Neuromodulation Devices Market Analysis, By End User, 2019 - 2030
9.2.4 Global Neuromodulation Devices Market Analysis, By Application, 2019 - 2030
9.3 Neuromodulation Devices Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.4 Neuromodulation Devices Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.5 Neuromodulation Devices Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.6 Neuromodulation Devices Market Rest of the World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 Latin America
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Neuromodulation Devices Vendors, 2018
10.1.2 Key Strategies Adopted by the Leading Players
Chapter 11 Company Profiles- Snapshot
11.1 St. Jude Medical, Inc.
11.2 LivaNova PLC
11.3 Boston Scientific Corporation
11.4 Aleva Neurotherapeutics SA
11.5 Bioness Inc.
11.6 EnteroMedics Inc
11.7 Nevro Corporation
11.8 NeuroPace Inc.
11.9 Synapse Biomedical, Inc.
11.10 Neurosigma, Inc.
11.11 Neuronetics, Inc.
11.12 Cyberonics, Inc.
11.13 BioControl Medical
11.14 Accellent
11.15 DynaMD
11.16 Soterix Medical, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
12.1 Research Methodology
12.2 Data Triangulation
12.3 Data Sources
12.4 Assumptions
12.5 Approach Adopted
12.6 Disclaimer
TABLE 2 Neuromodulation Devices Market, By External, 2018 - 2026 (USD Million)
TABLE 3 Neuromodulation Devices Market By Spinal Cord Stimulators (SCS), 2018 - 2026 (USD Million)
TABLE 4 Neuromodulation Devices Market By Deep Brain Stimulators (DBS), 2018 - 2026 (USD Million)
TABLE 5 Neuromodulation Devices Market By Vagus Nerve Stimulators (VNS), 2018 - 2026 (USD Million)
TABLE 6 Neuromodulation Devices Market By Sacral Nerve Stimulators (SNS), 2018 - 2026 (USD Million)
TABLE 7 Neuromodulation Devices Market By Transcranial Magnetic Stimulators (TMS), 2018 - 2026 (USD Million)
TABLE 8 Neuromodulation Devices Market By Hospitals, 2018 - 2026 (USD Million)
TABLE 9 Neuromodulation Devices Market By Specialty Clinics, 2018 - 2026 (USD Million)
TABLE 10 Neuromodulation Devices Market By Pain Management, 2018 - 2026 (USD Million)
TABLE 11 Neuromodulation Devices Market By Neurological Disorders, 2018 - 2026 (USD Million)
TABLE 12 Neuromodulation Devices Market By Respiratory Disorders, 2018 - 2026 (USD Million)
TABLE 13 Global Neuromodulation Devices Market Value, By Type, 2019 - 2030 (US$ Mn)
TABLE 14 Global Neuromodulation Devices Market Value, By Product Type, 2019 - 2030 (US$ Mn)
TABLE 15 Global Neuromodulation Devices Market Value, By End User, 2019 - 2030 (US$ Mn)
TABLE 16 Global Neuromodulation Devices Market Value, By Application, 2019 - 2030 (US$ Mn)
TABLE 17 Neuromodulation Devices Market Analysis by North America, By Country (USD Million), 2018-2026
TABLE 18 U.S. Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 19 U.S. Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 20 U.S. Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 21 U.S. Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 22 Canada Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 23 Canada Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 24 Canada Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 25 Canada Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 26 Mexico Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 27 Mexico Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 28 Mexico Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 29 Mexico Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 30 Neuromodulation Devices Market Analysis by Europe by Country (USD Million), 2018-2026
TABLE 31 Germany Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 32 GermanyNeuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 33 Germany Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 34 Europe Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 35 United Kingdom Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 36 United Kingdom Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 37 United Kingdom Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 38 United Kingdom Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 39 France Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 40 France Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 41 France Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 42 France Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 43 Italy Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 44 Italy Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 45 Italy Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 46 Italy Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 47 Rest Of Europe Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 48 Rest Of Europe Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 49 Rest of Europe Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 50 Rest of Europe Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 51 Neuromodulation Devices Market Analysis by Asia Pacific by Country (USD Million), 2018-2026
TABLE 52 China Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 53 China Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 54 China Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 55 China Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 56 Japan Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 57 Japan Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 58 Japan Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 59 Japan Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 60 IndiaNeuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 61 IndiaNeuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 62 India Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 63 India Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 64 Rest of APAC Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 65 Rest of APAC Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 66 Rest of APAC Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 67 Rest of APAC Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 68 Neuromodulation Devices Market Analysis by Rest of the World , by Region(USD Million), 2018-2026
TABLE 69 Middle East & Africa (MEA)Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 70 Middle East & Africa (MEA)Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 71 Middle East & Africa (MEA)Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 72 Middle East & Africa Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 73 Latin America Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 74 Latin America Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 75 Latin America Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 76 Latin America Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
FIG. 2 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
FIG. 3 Global Neuromodulation Devices Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 4 Global Neuromodulation Devices Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 5 Global Neuromodulation Devices Market Value Contribution, By End-User, 2019 & 2026 (%)
FIG. 6 Global Neuromodulation Devices Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 7 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
FIG. 8 North America Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 9 Neuromodulation Devices By Type North America
FIG. 10 Neuromodulation Devices Market By Product Type North America
FIG. 11 Neuromodulation Devices By End User North America
FIG. 12 Neuromodulation Devices By Application North America
FIG. 13 Neuromodulation Devices U.S. outlook, 2019 & 2026
FIG. 14 Neuromodulation Devices Canada outlook, 2019 & 2026
FIG. 15 Neuromodulation Devices Mexico outlook, 2019 & 2026
FIG. 16 Europe Neuromodulation Devices Market By Country (USD Million), 2019 - 2030, (US$ Mn)
FIG. 17 Neuromodulation Devices Market Type Europe
FIG. 18 Neuromodulation Devices Market Product Type Europe
FIG. 19 Neuromodulation Devices Market End User Europe
FIG. 20 Neuromodulation Devices Market Application Europe
FIG. 21 Neuromodulation Devices Germany outlook, 2019 & 2026
FIG. 22 Neuromodulation Devices United Kingdom outlook, 2019 & 2026
FIG. 23 Neuromodulation Devices France outlook, 2019 & 2026
FIG. 24 Neuromodulation Devices Italy outlook, 2019 & 2026
FIG. 25 Neuromodulation Devices Rest Of Europe outlook, 2019 & 2026
FIG. 26 Asia Pacific Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 27 Neuromodulation Devices Market Type Asia Pacific
FIG. 28 Neuromodulation Devices Market Product Type Asia Pacific
FIG. 29 Neuromodulation Devices Market End User Asia Pacific
FIG. 30 Neuromodulation Devices Market Application Asia Pacific
FIG. 31 Neuromodulation Devices China outlook, 2019 & 2026
FIG. 32 Neuromodulation Devices Japan outlook, 2019 & 2026
FIG. 33 Neuromodulation Devices India outlook, 2019 & 2026
FIG. 34 Neuromodulation Devices Rest of APAC outlook, 2019 & 2026
FIG. 35 Rest of the World Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 36 Neuromodulation Devices Market Type Rest of the World
FIG. 37 Neuromodulation Devices Market Product Type Rest of the World
FIG. 38 Neuromodulation Devices Market End User Rest of the World
FIG. 39 Neuromodulation Devices Market Application Rest of the World
FIG. 40 Neuromodulation Devices Middle East & Africa (MEA)outlook, 2019 & 2026
FIG. 41 Neuromodulation Devices Latin America outlook, 2019 & 2026
FIG. 43 Global Neuromodulation Devices Market: Research Methodology
FIG. 44 Top-Down and Bottom Up Approach
Companies Mentioned
Abbott
Boston Scientific
Brainsway
Helius Medical
INBRAIN Neuroelectronics
LivaNova
Mainstay Medical
Magnus Medical
Medtronic
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global Neuromodulation Devices Market Forces
3.1 Whats Driving the Market
3.2 Porters Five Forces Analysis
3.2.1 Power of Suppliers
3.2.2 Threats From New Entrants
3.2.3 Power of Buyer
3.2.4 Threat From Substitute Product Type
3.2.5 Degree of Competition
Chapter 4 Global Neuromodulation Devices Market -Industry Snapshots
4.1 Overview
4.1.1 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
4.2 Market Overview
4.2.1 Drivers Analysis
4.2.2 Restraint/Challenges analysis
4.2.3 Opportunity Analysis
4.3 Supply Chain/Value Chain Analysis
4.4 Market SWOT Analysis
Chapter 5 Global Neuromodulation Devices Market Analysis, By Type
5.1 Overview
5.2 Internal
5.3 External
Chapter 6 Global Neuromodulation Devices Market Analysis, by Product Type
6.1 Overview
6.1.1 Spinal Cord Stimulators (SCS)
6.1.2 Deep Brain Stimulators (DBS)
6.1.3 Vagus Nerve Stimulators (VNS)
6.1.4 Sacral Nerve Stimulators (SNS)
6.1.5 Transcranial Magnetic Stimulators (TMS)
Chapter 7 Global Neuromodulation Devices Market Analysis, by End-User
7.1 Overview
7.1.1 Hospitals
7.1.2 Specialty Clinics
Chapter 8 Global Neuromodulation Devices Market Analysis, by Application
8.1 Overview
8.1.1 Pain Management
8.1.2 Neurological Disorders
8.1.3 Respiratory Disorders
Chapter 9 Neuromodulation Devices Market Analysis by Region
9.1 Key Findings for Neuromodulation Devices Market- By region
9.2 Overview
9.2.1 Global Neuromodulation Devices Market Analysis, By Type, 2019 - 2030
9.2.2 Global Neuromodulation Devices Market Analysis, By Product Type, 2019 - 2030
9.2.3 Global Neuromodulation Devices Market Analysis, By End User, 2019 - 2030
9.2.4 Global Neuromodulation Devices Market Analysis, By Application, 2019 - 2030
9.3 Neuromodulation Devices Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.4 Neuromodulation Devices Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.5 Neuromodulation Devices Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.6 Neuromodulation Devices Market Rest of the World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 Latin America
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Neuromodulation Devices Vendors, 2018
10.1.2 Key Strategies Adopted by the Leading Players
Chapter 11 Company Profiles- Snapshot
11.1 St. Jude Medical, Inc.
11.2 LivaNova PLC
11.3 Boston Scientific Corporation
11.4 Aleva Neurotherapeutics SA
11.5 Bioness Inc.
11.6 EnteroMedics Inc
11.7 Nevro Corporation
11.8 NeuroPace Inc.
11.9 Synapse Biomedical, Inc.
11.10 Neurosigma, Inc.
11.11 Neuronetics, Inc.
11.12 Cyberonics, Inc.
11.13 BioControl Medical
11.14 Accellent
11.15 DynaMD
11.16 Soterix Medical, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
12.1 Research Methodology
12.2 Data Triangulation
12.3 Data Sources
12.4 Assumptions
12.5 Approach Adopted
12.6 Disclaimer
List Of Tables
TABLE 1 Neuromodulation Devices Market, By Internal, 2018 - 2026 (USD Million)TABLE 2 Neuromodulation Devices Market, By External, 2018 - 2026 (USD Million)
TABLE 3 Neuromodulation Devices Market By Spinal Cord Stimulators (SCS), 2018 - 2026 (USD Million)
TABLE 4 Neuromodulation Devices Market By Deep Brain Stimulators (DBS), 2018 - 2026 (USD Million)
TABLE 5 Neuromodulation Devices Market By Vagus Nerve Stimulators (VNS), 2018 - 2026 (USD Million)
TABLE 6 Neuromodulation Devices Market By Sacral Nerve Stimulators (SNS), 2018 - 2026 (USD Million)
TABLE 7 Neuromodulation Devices Market By Transcranial Magnetic Stimulators (TMS), 2018 - 2026 (USD Million)
TABLE 8 Neuromodulation Devices Market By Hospitals, 2018 - 2026 (USD Million)
TABLE 9 Neuromodulation Devices Market By Specialty Clinics, 2018 - 2026 (USD Million)
TABLE 10 Neuromodulation Devices Market By Pain Management, 2018 - 2026 (USD Million)
TABLE 11 Neuromodulation Devices Market By Neurological Disorders, 2018 - 2026 (USD Million)
TABLE 12 Neuromodulation Devices Market By Respiratory Disorders, 2018 - 2026 (USD Million)
TABLE 13 Global Neuromodulation Devices Market Value, By Type, 2019 - 2030 (US$ Mn)
TABLE 14 Global Neuromodulation Devices Market Value, By Product Type, 2019 - 2030 (US$ Mn)
TABLE 15 Global Neuromodulation Devices Market Value, By End User, 2019 - 2030 (US$ Mn)
TABLE 16 Global Neuromodulation Devices Market Value, By Application, 2019 - 2030 (US$ Mn)
TABLE 17 Neuromodulation Devices Market Analysis by North America, By Country (USD Million), 2018-2026
TABLE 18 U.S. Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 19 U.S. Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 20 U.S. Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 21 U.S. Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 22 Canada Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 23 Canada Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 24 Canada Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 25 Canada Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 26 Mexico Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 27 Mexico Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 28 Mexico Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 29 Mexico Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 30 Neuromodulation Devices Market Analysis by Europe by Country (USD Million), 2018-2026
TABLE 31 Germany Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 32 GermanyNeuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 33 Germany Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 34 Europe Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 35 United Kingdom Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 36 United Kingdom Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 37 United Kingdom Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 38 United Kingdom Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 39 France Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 40 France Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 41 France Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 42 France Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 43 Italy Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 44 Italy Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 45 Italy Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 46 Italy Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 47 Rest Of Europe Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 48 Rest Of Europe Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 49 Rest of Europe Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 50 Rest of Europe Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 51 Neuromodulation Devices Market Analysis by Asia Pacific by Country (USD Million), 2018-2026
TABLE 52 China Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 53 China Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 54 China Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 55 China Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 56 Japan Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 57 Japan Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 58 Japan Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 59 Japan Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 60 IndiaNeuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 61 IndiaNeuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 62 India Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 63 India Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 64 Rest of APAC Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 65 Rest of APAC Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 66 Rest of APAC Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 67 Rest of APAC Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 68 Neuromodulation Devices Market Analysis by Rest of the World , by Region(USD Million), 2018-2026
TABLE 69 Middle East & Africa (MEA)Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 70 Middle East & Africa (MEA)Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 71 Middle East & Africa (MEA)Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 72 Middle East & Africa Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
TABLE 73 Latin America Neuromodulation Devices Market, By Type, 2018 - 2026 (USD Million)
TABLE 74 Latin America Neuromodulation Devices Market, By Product Type, 2018 - 2026 (USD Million)
TABLE 75 Latin America Neuromodulation Devices Market, By End User, 2018 - 2026 (USD Million)
TABLE 76 Latin America Neuromodulation Devices Market, By Application, 2018 - 2026 (USD Million)
List Of Figures
FIG. 1 Global Neuromodulation Devices : Market SegmentationFIG. 2 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
FIG. 3 Global Neuromodulation Devices Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 4 Global Neuromodulation Devices Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 5 Global Neuromodulation Devices Market Value Contribution, By End-User, 2019 & 2026 (%)
FIG. 6 Global Neuromodulation Devices Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 7 Global Neuromodulation Devices Market Value, 2019 - 2030, (US$ Mn)
FIG. 8 North America Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 9 Neuromodulation Devices By Type North America
FIG. 10 Neuromodulation Devices Market By Product Type North America
FIG. 11 Neuromodulation Devices By End User North America
FIG. 12 Neuromodulation Devices By Application North America
FIG. 13 Neuromodulation Devices U.S. outlook, 2019 & 2026
FIG. 14 Neuromodulation Devices Canada outlook, 2019 & 2026
FIG. 15 Neuromodulation Devices Mexico outlook, 2019 & 2026
FIG. 16 Europe Neuromodulation Devices Market By Country (USD Million), 2019 - 2030, (US$ Mn)
FIG. 17 Neuromodulation Devices Market Type Europe
FIG. 18 Neuromodulation Devices Market Product Type Europe
FIG. 19 Neuromodulation Devices Market End User Europe
FIG. 20 Neuromodulation Devices Market Application Europe
FIG. 21 Neuromodulation Devices Germany outlook, 2019 & 2026
FIG. 22 Neuromodulation Devices United Kingdom outlook, 2019 & 2026
FIG. 23 Neuromodulation Devices France outlook, 2019 & 2026
FIG. 24 Neuromodulation Devices Italy outlook, 2019 & 2026
FIG. 25 Neuromodulation Devices Rest Of Europe outlook, 2019 & 2026
FIG. 26 Asia Pacific Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 27 Neuromodulation Devices Market Type Asia Pacific
FIG. 28 Neuromodulation Devices Market Product Type Asia Pacific
FIG. 29 Neuromodulation Devices Market End User Asia Pacific
FIG. 30 Neuromodulation Devices Market Application Asia Pacific
FIG. 31 Neuromodulation Devices China outlook, 2019 & 2026
FIG. 32 Neuromodulation Devices Japan outlook, 2019 & 2026
FIG. 33 Neuromodulation Devices India outlook, 2019 & 2026
FIG. 34 Neuromodulation Devices Rest of APAC outlook, 2019 & 2026
FIG. 35 Rest of the World Neuromodulation Devices Market By Country (USD Million), 2019 - 2030
FIG. 36 Neuromodulation Devices Market Type Rest of the World
FIG. 37 Neuromodulation Devices Market Product Type Rest of the World
FIG. 38 Neuromodulation Devices Market End User Rest of the World
FIG. 39 Neuromodulation Devices Market Application Rest of the World
FIG. 40 Neuromodulation Devices Middle East & Africa (MEA)outlook, 2019 & 2026
FIG. 41 Neuromodulation Devices Latin America outlook, 2019 & 2026
FIG. 43 Global Neuromodulation Devices Market: Research Methodology
FIG. 44 Top-Down and Bottom Up Approach
Companies Mentioned
Abbott
Boston Scientific
Brainsway
Helius Medical
INBRAIN Neuroelectronics
LivaNova
Mainstay Medical
Magnus Medical
Medtronic
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportGlobal Neuromodulation Devices Market Research Report 2021-2025
Neuromodulation technology utilizes devices that bring about a change in nervous system either by stimulation or modulating brain activity. In the context of China-US trade war and COVID-19 epidemic, it
View ReportGlobal Neuromodulation Devices Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries
The Global market for Neuromodulation Devices is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027, from
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
